Data as of 4:00pm ET
| -0.04 / -2.00%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 2.97, with a high estimate of 4.00 and a low estimate of 1.00. The median estimate represents a +51.71% increase from the last price of 1.96.
The current consensus among 4 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.